Skip to content

Medical emergency? What to do

Breast cancer drug move gives hope to UK patients

3-RXPublished October 5, 20052 min read

Key points

  • Women diagnosed with early stage breast cancer are to be tested to see if they are suitable for treatment with the drug Herceptin, made by Switzerland's Roche Holding AG, Britain said on Wednesday.
  • Recent research has shown Herceptin can help patients with early stage breast cancer and campaigners have been fighting for it to be widely available on the state-funded National Health Service (NHS).
  • Health Secretary Patricia Hewitt said that from Wednesday all women diagnosed with early stage breast cancer would be tested for suitability for treatment with Herceptin.
  • Once the drug is licensed for use in early stage breast cancer it will be fast-tracked for use throughout the state-funded NHS.

Women diagnosed with early stage breast cancer are to be tested to see if they are suitable for treatment with the drug Herceptin, made by Switzerland's Roche Holding AG, Britain said on Wednesday.

The move could mean that the lives of 1,000 women a year in England could be saved - the same number saved by the national breast screening program, the Department of Health (DOH) said.

Recent research has shown Herceptin can help patients with early stage breast cancer and campaigners have been fighting for it to be widely available on the state-funded National Health Service (NHS).

The drug is currently only licensed for use in women with advanced breast cancer, although doctors can use their discretion to prescribe it in exceptional other cases.

Health Secretary Patricia Hewitt said that from Wednesday all women diagnosed with early stage breast cancer would be tested for suitability for treatment with Herceptin.

But women who have been diagnosed before Wednesday will not automatically be tested for the HER-2 receptor, which indicates whether a patient may benefit from Herceptin.

Once the drug is licensed for use in early stage breast cancer it will be fast-tracked for use throughout the state-funded NHS.

Roche expects to file a European application for early use of Herceptin in February next year.

"Herceptin has the potential to save many women's lives and I want to see it in widespread use on the NHS," Hewitt said.

Hewitt has already ordered Britain's drugs watchdog,the National Institute for Health and Clinical Excellence to fast track its assessment of the wider use of the drug.

Of the 35,000 women diagnosed with breast cancer in England each year, 20,000 would be suitable for testing, the DOH said. Some 5,000 may benefit from taking Herceptin.

Earlier this week, former nurse Barbara Clark won a legal battle to be given Herceptin.

Clark had threatened to use the Human Rights Act to force her doctors to prescribe the drug after she had been told she could not have the treatment because her cancer was not at an advanced stage.

Campaigners said they were concerned that the drug was not expected to be licensed until next year.

"Patients need to understand that the drug is not expected to be licensed until July 2006 at the earliest,," said Professor John Toy, medical director of Cancer Research UK. "A process to make the drug available as quickly as possible after licensing is especially important given this delay."

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underBreast Cancer
Cancer

Strong social ties benefit breast cancer patients

Breast cancer patients who have a strong social support system in the first year after diagnosis are less likely to die or have a recurrence of cancer, according to new research from Vanderbilt-Ingram Cancer Center…

3 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.